0001613377-19-000004.txt : 20190617
0001613377-19-000004.hdr.sgml : 20190617
20190617145803
ACCESSION NUMBER: 0001613377-19-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190617
DATE AS OF CHANGE: 20190617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STRAYER DAVID R
CENTRAL INDEX KEY: 0001270074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-27072
FILM NUMBER: 19901215
MAIL ADDRESS:
STREET 1: 600 MAIN STREET
STREET 2: SUITE 2
CITY: RIVERTON
STATE: NJ
ZIP: 08077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC
CENTRAL INDEX KEY: 0000946644
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 520845822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
BUSINESS PHONE: 215-988-0080
MAIL ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-03-25
0
0000946644
HEMISPHERX BIOPHARMA INC
HEB
0001270074
STRAYER DAVID R
604 MAIN STREET
RIVERTON
NJ
08077
0
1
0
0
Chief Science/Medical Officer
Common Stock
2019-03-25
4
C
0
50000
A
94304
D
Common Stock
2019-05-08
4
C
0
35000
A
129304
D
Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the ten shares issued.
Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares.
David R. Strayer
2019-06-17